{"id":"https://openalex.org/W1972550125","doi":"https://doi.org/10.1111/bjh.12488","title":"A phase I/II trial of bortezomib combined concurrently with gemcitabine for relapsed or refractory DLBCL and peripheral T \u2010cell lymphomas","display_name":"A phase I/II trial of bortezomib combined concurrently with gemcitabine for relapsed or refractory DLBCL and peripheral T \u2010cell lymphomas","publication_year":2013,"publication_date":"2013-08-08","ids":{"openalex":"https://openalex.org/W1972550125","doi":"https://doi.org/10.1111/bjh.12488","mag":"1972550125","pmid":"https://pubmed.ncbi.nlm.nih.gov/23927371"},"language":"en","primary_location":{"id":"doi:10.1111/bjh.12488","doi":"https://doi.org/10.1111/bjh.12488","is_oa":true,"landing_page_url":"https://doi.org/10.1111/bjh.12488","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bjh.12488","source":{"id":"https://openalex.org/S153015021","display_name":"British Journal of Haematology","issn_l":"0007-1048","issn":["0007-1048","1365-2141"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Haematology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bjh.12488","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5064091455","display_name":"Andrew M. Evens","orcid":"https://orcid.org/0000-0002-6900-1824","observed_orcids":["https://orcid.org/0000-0002-6900-1824"]},"institutions":[{"id":"https://openalex.org/I121934306","display_name":"Tufts University","ror":"https://ror.org/05wvpxv85","country_code":"US","type":"education","lineage":["https://openalex.org/I121934306"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Andrew M. Evens","raw_affiliation_strings":["Division of Hematology/Oncology; Tufts University School of Medicine; Boston; MA; USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology/Oncology; Tufts University School of Medicine; Boston; MA; USA","institution_ids":["https://openalex.org/I121934306"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013430443","display_name":"Steven T. Rosen","orcid":"https://orcid.org/0000-0002-8818-7724","observed_orcids":["https://orcid.org/0000-0002-8818-7724"]},"institutions":[{"id":"https://openalex.org/I111979921","display_name":"Northwestern University","ror":"https://ror.org/000e0be47","country_code":"US","type":"education","lineage":["https://openalex.org/I111979921"]},{"id":"https://openalex.org/I4390039227","display_name":"Robert H. Lurie Comprehensive Cancer Center of Northwestern University","ror":"https://ror.org/02p4far57","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210147348","https://openalex.org/I4390039227"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Steven T. Rosen","raw_affiliation_strings":["Division of Hematology/Oncology Robert H. Lurie Comprehensive Cancer Center Feinberg School of Medicine Northwestern University Chicago IL USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology/Oncology Robert H. Lurie Comprehensive Cancer Center Feinberg School of Medicine Northwestern University Chicago IL USA","institution_ids":["https://openalex.org/I111979921","https://openalex.org/I4390039227"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077814055","display_name":"Irene Helenowski","orcid":"https://orcid.org/0000-0003-1606-9013","observed_orcids":["https://orcid.org/0000-0003-1606-9013","https://orcid.org/0009-0007-1815-8331"]},"institutions":[{"id":"https://openalex.org/I111979921","display_name":"Northwestern University","ror":"https://ror.org/000e0be47","country_code":"US","type":"education","lineage":["https://openalex.org/I111979921"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Irene Helenowski","raw_affiliation_strings":["Department of Preventive Medicine Northwestern University Chicago IL USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Preventive Medicine Northwestern University Chicago IL USA","institution_ids":["https://openalex.org/I111979921"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008824892","display_name":"Justin Paul Kline","orcid":"https://orcid.org/0000-0002-2967-6448","observed_orcids":["https://orcid.org/0000-0002-2967-6448"]},"institutions":[{"id":"https://openalex.org/I40347166","display_name":"University of Chicago","ror":"https://ror.org/024mw5h28","country_code":"US","type":"education","lineage":["https://openalex.org/I40347166"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Justin Kline","raw_affiliation_strings":["Section of Hematology/Oncology University of Chicago Chicago IL USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Section of Hematology/Oncology University of Chicago Chicago IL USA","institution_ids":["https://openalex.org/I40347166"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Annette Larsen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I166722992","display_name":"University of Massachusetts Chan Medical School","ror":"https://ror.org/0464eyp60","country_code":"US","type":"education","lineage":["https://openalex.org/I166722992"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Annette Larsen","raw_affiliation_strings":["Cancer Research Office The University of Massachusetts Medical School Worcester MA USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Research Office The University of Massachusetts Medical School Worcester MA USA","institution_ids":["https://openalex.org/I166722992"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020019413","display_name":"Jennifer S. Colvin","orcid":"https://orcid.org/0009-0006-4032-7691","observed_orcids":["https://orcid.org/0009-0006-4032-7691"]},"institutions":[{"id":"https://openalex.org/I166722992","display_name":"University of Massachusetts Chan Medical School","ror":"https://ror.org/0464eyp60","country_code":"US","type":"education","lineage":["https://openalex.org/I166722992"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jennifer Colvin","raw_affiliation_strings":["Cancer Research Office; The University of Massachusetts Medical School; Worcester; MA; USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Research Office; The University of Massachusetts Medical School; Worcester; MA; USA","institution_ids":["https://openalex.org/I166722992"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003670546","display_name":"Jane N. Winter","orcid":"https://orcid.org/0000-0001-7542-3305","observed_orcids":["https://orcid.org/0000-0001-7542-3305"]},"institutions":[{"id":"https://openalex.org/I111979921","display_name":"Northwestern University","ror":"https://ror.org/000e0be47","country_code":"US","type":"education","lineage":["https://openalex.org/I111979921"]},{"id":"https://openalex.org/I4390039227","display_name":"Robert H. Lurie Comprehensive Cancer Center of Northwestern University","ror":"https://ror.org/02p4far57","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210147348","https://openalex.org/I4390039227"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jane N. Winter","raw_affiliation_strings":["Division of Hematology/Oncology Robert H. Lurie Comprehensive Cancer Center Feinberg School of Medicine Northwestern University Chicago IL USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology/Oncology Robert H. Lurie Comprehensive Cancer Center Feinberg School of Medicine Northwestern University Chicago IL USA","institution_ids":["https://openalex.org/I111979921","https://openalex.org/I4390039227"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044134864","display_name":"Koen van Besien","orcid":"https://orcid.org/0000-0002-8164-6211","observed_orcids":["https://orcid.org/0000-0002-8164-6211"]},"institutions":[{"id":"https://openalex.org/I205783295","display_name":"Cornell University","ror":"https://ror.org/05bnh6r87","country_code":"US","type":"education","lineage":["https://openalex.org/I205783295"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Koen M. van Besien","raw_affiliation_strings":["Division of Hematology Cornell School of Medicine New York NY USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology Cornell School of Medicine New York NY USA","institution_ids":["https://openalex.org/I205783295"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010130956","display_name":"Leo I. Gordon","orcid":"https://orcid.org/0000-0003-1666-7064","observed_orcids":["https://orcid.org/0000-0003-1666-7064"]},"institutions":[{"id":"https://openalex.org/I111979921","display_name":"Northwestern University","ror":"https://ror.org/000e0be47","country_code":"US","type":"education","lineage":["https://openalex.org/I111979921"]},{"id":"https://openalex.org/I4390039227","display_name":"Robert H. Lurie Comprehensive Cancer Center of Northwestern University","ror":"https://ror.org/02p4far57","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210147348","https://openalex.org/I4390039227"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Leo I. Gordon","raw_affiliation_strings":["Division of Hematology/Oncology Robert H. Lurie Comprehensive Cancer Center Feinberg School of Medicine Northwestern University Chicago IL USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology/Oncology Robert H. Lurie Comprehensive Cancer Center Feinberg School of Medicine Northwestern University Chicago IL USA","institution_ids":["https://openalex.org/I111979921","https://openalex.org/I4390039227"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5005159945","display_name":"Sonali M. Smith","orcid":"https://orcid.org/0000-0002-9893-4949","observed_orcids":["https://orcid.org/0000-0002-9893-4949"]},"institutions":[{"id":"https://openalex.org/I40347166","display_name":"University of Chicago","ror":"https://ror.org/024mw5h28","country_code":"US","type":"education","lineage":["https://openalex.org/I40347166"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sonali M. Smith","raw_affiliation_strings":["Section of Hematology/Oncology University of Chicago Chicago IL USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Section of Hematology/Oncology University of Chicago Chicago IL USA","institution_ids":["https://openalex.org/I40347166"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":6,"corresponding_author_ids":["https://openalex.org/A5064091455"],"corresponding_institution_ids":["https://openalex.org/I121934306"],"apc_list":{"value":5190,"currency":"USD","value_usd":5190},"apc_paid":null,"fwci":5.7875,"has_fulltext":true,"cited_by_count":45,"citation_normalized_percentile":{"value":0.96517457,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"163","issue":"1","first_page":"55","last_page":"61"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10685","display_name":"Viral-associated cancers and disorders","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/bortezomib","display_name":"bortezomib","score":0.9990000128746033},{"id":"https://openalex.org/keywords/gemcitabine","display_name":"gemcitabine","score":1.0},{"id":"https://openalex.org/keywords/relapsed-refractory-lymphoma","display_name":"relapsed/refractory lymphoma","score":0.921999990940094},{"id":"https://openalex.org/keywords/diffuse-large-b-cell-lymphoma","display_name":"diffuse large B-cell lymphoma","score":0.9990000128746033},{"id":"https://openalex.org/keywords/peripheral-t-cell-lymphoma","display_name":"peripheral T-cell lymphoma","score":1.0},{"id":"https://openalex.org/keywords/proteasome-inhibitors","display_name":"proteasome inhibitors","score":0.75},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.6809999942779541},{"id":"https://openalex.org/keywords/neutropenia","display_name":"neutropenia","score":0.7419999837875366},{"id":"https://openalex.org/keywords/thrombocytopenia","display_name":"thrombocytopenia","score":0.9440000057220459},{"id":"https://openalex.org/keywords/treatment-related-toxicity","display_name":"treatment toxicity","score":0.5600000023841858},{"id":"https://openalex.org/keywords/overall-response-rate","display_name":"overall response rate","score":0.7080000042915344}],"concepts":[{"id":"https://openalex.org/C2777478702","wikidata":"https://www.wikidata.org/wiki/Q419319","display_name":"Bortezomib","level":3,"score":0.8110799789428711},{"id":"https://openalex.org/C2780258809","wikidata":"https://www.wikidata.org/wiki/Q414143","display_name":"Gemcitabine","level":3,"score":0.8010431528091431},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7648941874504089},{"id":"https://openalex.org/C2777063308","wikidata":"https://www.wikidata.org/wiki/Q1435822","display_name":"Neutropenia","level":3,"score":0.7071770429611206},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.672165036201477},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6425181031227112},{"id":"https://openalex.org/C142424586","wikidata":"https://www.wikidata.org/wiki/Q7307572","display_name":"Refractory (planetary science)","level":2,"score":0.6316432952880859},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.4756952226161957},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.4696837067604065},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.45425015687942505},{"id":"https://openalex.org/C2777891184","wikidata":"https://www.wikidata.org/wiki/Q7168693","display_name":"Peripheral T-cell lymphoma","level":4,"score":0.43700867891311646},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.43550926446914673},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.35471874475479126},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.31412842869758606},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.3112628757953644},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.18166521191596985},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.16436800360679626},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.1514929234981537},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.14957529306411743},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.072071373462677},{"id":"https://openalex.org/C87355193","wikidata":"https://www.wikidata.org/wiki/Q411","display_name":"Astrobiology","level":1,"score":0.0},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000069286","descriptor_name":"Bortezomib","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000093542","descriptor_name":"Gemcitabine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001897","descriptor_name":"Boronic Acids","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D003841","descriptor_name":"Deoxycytidine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D003841","descriptor_name":"Deoxycytidine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011719","descriptor_name":"Pyrazines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D012008","descriptor_name":"Recurrence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016403","descriptor_name":"Lymphoma, Large B-Cell, Diffuse","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D016403","descriptor_name":"Lymphoma, Large B-Cell, Diffuse","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D016403","descriptor_name":"Lymphoma, Large B-Cell, Diffuse","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D016411","descriptor_name":"Lymphoma, T-Cell, Peripheral","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D016411","descriptor_name":"Lymphoma, T-Cell, Peripheral","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D016411","descriptor_name":"Lymphoma, T-Cell, Peripheral","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1111/bjh.12488","doi":"https://doi.org/10.1111/bjh.12488","is_oa":true,"landing_page_url":"https://doi.org/10.1111/bjh.12488","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bjh.12488","source":{"id":"https://openalex.org/S153015021","display_name":"British Journal of Haematology","issn_l":"0007-1048","issn":["0007-1048","1365-2141"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Haematology","raw_type":"journal-article"},{"id":"pmid:23927371","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23927371","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British journal of haematology","raw_type":"Clinical Trial, Phase I"}],"best_oa_location":{"id":"doi:10.1111/bjh.12488","doi":"https://doi.org/10.1111/bjh.12488","is_oa":true,"landing_page_url":"https://doi.org/10.1111/bjh.12488","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bjh.12488","source":{"id":"https://openalex.org/S153015021","display_name":"British Journal of Haematology","issn_l":"0007-1048","issn":["0007-1048","1365-2141"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Haematology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W1972550125.pdf","grobid_xml":"https://content.openalex.org/works/W1972550125.grobid-xml"},"referenced_works_count":41,"referenced_works":["https://openalex.org/W13341330","https://openalex.org/W100548313","https://openalex.org/W1530754204","https://openalex.org/W1867755102","https://openalex.org/W1912693401","https://openalex.org/W1972409681","https://openalex.org/W1981913733","https://openalex.org/W1986778063","https://openalex.org/W1988587254","https://openalex.org/W1990670396","https://openalex.org/W1998252625","https://openalex.org/W2000044224","https://openalex.org/W2012098025","https://openalex.org/W2023338496","https://openalex.org/W2038890616","https://openalex.org/W2041351969","https://openalex.org/W2060594675","https://openalex.org/W2067637255","https://openalex.org/W2068410289","https://openalex.org/W2079523831","https://openalex.org/W2080199075","https://openalex.org/W2088108957","https://openalex.org/W2089335774","https://openalex.org/W2104740131","https://openalex.org/W2111677629","https://openalex.org/W2119680582","https://openalex.org/W2121500163","https://openalex.org/W2122684890","https://openalex.org/W2123807140","https://openalex.org/W2124482385","https://openalex.org/W2127358965","https://openalex.org/W2134210438","https://openalex.org/W2140187932","https://openalex.org/W2142867377","https://openalex.org/W2168692062","https://openalex.org/W2172003817","https://openalex.org/W2185085274","https://openalex.org/W2315006307","https://openalex.org/W2489549603","https://openalex.org/W2564513603","https://openalex.org/W2999065750"],"related_works":["https://openalex.org/W2547216979","https://openalex.org/W2567614364","https://openalex.org/W2592367564","https://openalex.org/W2117460825","https://openalex.org/W1995971283","https://openalex.org/W2489529886","https://openalex.org/W2341289653","https://openalex.org/W2095233041","https://openalex.org/W2134646407","https://openalex.org/W3097827157"],"abstract_inverted_index":{"There":[0],"remains":[1],"an":[2],"unmet":[3],"therapeutic":[4],"need":[5],"for":[6,135,139,147],"patients":[7,154],"with":[8,26,35,121],"relapsed/refractory":[9,52,208],"diffuse":[10],"large":[11],"B-cell":[12],"lymphoma":[13,18],"(DLBCL)":[14],"and":[15,54,61,97],"peripheral":[16],"T-cell":[17],"(PTCL).":[19],"We":[20],"conducted":[21],"a":[22,183,203],"phase":[23],"I/II":[24],"trial":[25],"bortezomib":[27,96],"(dose-escalated":[28],"to":[29,94,182],"1\u00b76":[30],"mg/m(2)":[31,38],")":[32,39],"given":[33,170],"concurrently":[34],"gemcitabine":[36,98],"(800":[37],"days":[40,99,171],"1":[41,100,172],"+":[42,101,173],"8":[43,174],"q21":[44,175],"d.":[45],"Of":[46],"32":[47],"patients,":[48,70,113],"16":[49],"each":[50],"had":[51,63],"PTCL":[53,148,153,209],"DLBCL.":[55],"Median":[56],"prior":[57],"therapies":[58],"were":[59],"3":[60],"35%":[62],"failed":[64],"transplant.":[65],"Among":[66,111,151],"the":[67,90,114,157,211],"first":[68],"18":[69],"67%":[71],"experienced":[72],"grade":[73,77],"3/4":[74,78],"neutropenia":[75],"and/or":[76],"thrombocytopenia":[79],"resulting":[80],"in":[81,107,197,207],"repeated":[82],"treatment":[83,188],"delays":[84],"(relative":[85],"dose":[86],"intensity:":[87],"46%).":[88],"Thus,":[89],"study":[91],"was":[92,119,141,163,177,195,202],"amended":[93],"give":[95],"15":[102],"q28":[103],"d,":[104],"which":[105,132],"resulted":[106],"markedly":[108],"improved":[109],"tolerability.":[110],"all":[112],"overall":[115],"response":[116],"rate":[117],"(ORR)":[118],"24%":[120],"19%":[122],"complete":[123],"remission":[124],"(CR;":[125],"intent-to-treat":[126],"(ITT)":[127],"ORR":[128,138,160],"16%,":[129],"CR":[130],"13%),":[131],"met":[133],"criteria":[134],"futility.":[136],"The":[137],"DLBCL":[140],"10%":[142],"(CR":[143,149,165],"10%)":[144],"vs.":[145],"36%":[146],"27%).":[150],"6":[152],"treated":[155],"on":[156],"modified":[158,212],"schedule,":[159],"by":[161],"ITT":[162],"50%":[164],"30%).":[166],"Altogether,":[167],"concurrent":[168],"bortezomib/gemcitabine":[169],"d":[176],"not":[178],"tolerable,":[179],"while":[180],"modification":[181],"bi-monthly":[184],"schedule":[185],"allowed":[186],"consistent":[187],"delivery.":[189],"Whereas":[190],"efficacy":[191],"of":[192,205],"this":[193],"combination":[194],"low":[196],"heavily":[198],"pre-treated":[199],"DLBCL,":[200],"there":[201],"signal":[204],"activity":[206],"utilizing":[210],"schedule.":[213]},"counts_by_year":[{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":6},{"year":2017,"cited_by_count":5},{"year":2016,"cited_by_count":8},{"year":2015,"cited_by_count":6},{"year":2014,"cited_by_count":5},{"year":2013,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}